Trial Profile
Clinical Trial to Evaluate ANT-1207 in the Treatment of Primary Axillary Hyperhidrosis in Adults
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Sep 2017
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Hyperhidrosis
- Focus Therapeutic Use
- Sponsors Anterios
- 25 Mar 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 04 Jan 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Mar 2016, as reported by ClinicalTrials.gov.
- 04 Jan 2016 According to ClinicalTrials.gov record, status changed from recruiting to active, no longer recruiting.